Relevance of
Intellectual
Property |
|
Intellectual
Property is like any other property and the developed
countries respect and comply with Intellectual Property
India has to do the same. Historically, India was the
seat of knowledge and wisdom, and India was the leader
in most disciplines. Nalanda and Takshila were the seats
of wisdom...
More Details...
|
|
Markets |
|
Regulated Markets
(USA, EUROPE)
Non-Regulated
(SOUTH EAST, ASIA, AFRICA, LATIN
AMERICA, CIS ETC)
|
|
| |
WHO-GMP
Approved
manufacturing facilities |
 |
|
WHO-GMP Approved manufacturing
facilities for Oncology, General tablets and
cephalosporin
|
|
| |
|
|
|
Cefi XL is the No.1
new product launched in India
Cefi XL
breaks all records.!
Cefi XL is the No. 1 new product, out of all new
products launched in India in last 24 months as per IMS
ORG July 2006.
Cefi XL is patented in India, The U.S. and European
patent are awaited.
Cefi XL (Cefixime + Cloxacillin +
Lactobacillus is effective against staphylococci aureus.
Intellectual Property
Alendronate
sodium
U.S. Patent no.6783772 .
European Application.EP05250879.
PCT Application PCT/IN06/00193, Bangladesh Patent
-83/2005,
Pakistan Patent 251/2005 for Cefi-XL
Indian Patent granted for FDC of Cefixime + Cloxacillin
+
Lactobacillus tablet(Cefi-XL), Cefixime once
a day tablet
(Cefi-OD), Camylofin & Diclofenac inj., Methocarbamol & Diclofenac
Gel, Methocarbamol & Nimesulide Tablet
Monthly incentive for medical
representatives
Incentive from Rs.75,000
per month sales onwards.
Incentives paid on monthly basis ranging from 3% to 7%
of sales with minimal targets of maximum Rs.1 lac
to
Rs.1.5 lacs. Newly launched territories have incentives
starting from Rs.75,000 per month sales for the initial
6 months.
High Base territories have Special Monthly Allowances from
Rs.1000 – Rs.5000 per month.
Marketing Infrastructure expanded in India
Klab's 1200 Medical Representatives meet 245,000 Doctors and
125,000 Pharmacies every month, with special focus on
Gastroenterologists, General Surgeons, Gynaecologists,
Orthopedic Surgeons, Pediatricians, Physicians and
Oncologists.
K-CHIRAL’S.
KLab has developed multifunctional Chiral Pools of
Carbohydrates, Monosaccharides, Amino Alcohols, Oxazolidines etc
K-Dendrimers.
KLab is developing an
economical dendrimer system for cosmetic applications and drug
delivery.
High throughtout screening for NCE’s.
KLab can do the sequencing of Plasmid DNA and PKR products.
We have access to In Vitro transcription and translation facilities.
We can screen NCE’s for biological activities and do drug protein binding Assays.
|
 "
In the Court Of Shri Manoj Kumar jain,
Additional District Judge , Delhi
M/s. Wisdom Pharma have recognized and acknowledged
M/s. Khandelwal Laboratories Pvt. Ltd / Mr. Sanjeev
Khandelwal to be the owner of the
Registered Patent No.197822 and have undertaken to this Hon'ble Court not to challenge the proprietary rights
of this patent at any point of time before any
Hon'ble Court / Tribunal and or any other statutory
body."
|
|
| |
|
|
| |
|
|
| |
|
